Sakane, Naoki http://orcid.org/0000-0002-2625-571X
Hirota, Yushi
Yamamoto, Akane
Miura, Junnosuke
Takaike, Hiroko
Hoshina, Sari
Toyoda, Masao
Saito, Nobumichi
Hosoda, Kiminori
Matsubara, Masaki
Tone, Atsuhito
Kawashima, Satoshi
Sawaki, Hideaki
Matsuda, Tomokazu
Domichi, Masayuki
Suganuma, Akiko
Sakane, Seiko
Murata, Takashi
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18ek0210104h0001, 19ek0210104h0002, 20ek0210104h0003)
Article History
Received: 16 March 2023
Accepted: 27 July 2023
First Online: 12 September 2023
Declarations
:
: YH received lecture fees from Eli Lilly, Sanofi, Abbott, Terumo and Sumitomo Pharma, and research expenses and grants from Sumitomo Pharma. JM received lecture fees from Terumo. MT received lecture fees from Abbott, Terumo and Sumitomo Pharma, Novo Nordisk, and Boehringer Ingelheim and subsides or donations from Cocokara fine Healthcare Inc., LifeScan Japan, Roche DC Japan, and SUPER LIGHT WATER CO., LTD. AT receives lecture fees from Eli Lilly, Sanofi, Abbott, and Terumo.TM received lecture fees from Eli Lilly. Other members declare no competing interests.
: This study conformed to the standards of the Declaration of Helsinki. The present study was approved by the Ethics Committee of the National Hospital Organization Kyoto Medical Center (No.19–072, approval date: January 20, 2020).
: Informed consent or substitute for it was obtained from all patients for being included in the study. Approval date of Registry and the Registration No. of the study/trial: Trial registration number: University hospital Medical Information Network (UMIN) Center: UMIN000039376).